Open AccessGLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT DECREASE THE RISK FOR CORONARY REVASCULARIZATION IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS
Author(s) -
Dimitrios Patoulias,
Alexandra Katsimardou,
Κonstantinos Imprialos,
Konstantinos Stavropoulos,
Fotios Siskos,
George Kassimis,
Konstantinos Petidis,
Christodoulos Papadopoulos,
Asterios Karagiannis,
Michael Doumas
Publication year - 2022
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000837028.88430.4f
Subject(s) - medicine , myocardial infarction , cardiology , coronary artery disease , revascularization , type 2 diabetes , type 2 diabetes mellitus , placebo , diabetes mellitus , endocrinology , pathology , alternative medicine